Therapeutic effect of omega‐3 fatty acids on T cell‐mediated autoimmune diseases

2020 ◽  
Vol 64 (8) ◽  
pp. 563-569
Author(s):  
Liu Ouyang ◽  
Yang Dan ◽  
Wenbin Hua ◽  
Zengwu Shao ◽  
Deyu Duan
2016 ◽  
Vol 785 ◽  
pp. 2-9 ◽  
Author(s):  
Tim Y. Hou ◽  
David N. McMurray ◽  
Robert S. Chapkin

2009 ◽  
Vol 145 (1) ◽  
pp. 84-86 ◽  
Author(s):  
Antonino Musolino ◽  
Michele Panebianco ◽  
Enrico Zendri ◽  
Marcello Santini ◽  
Sergio Di Nuzzo ◽  
...  

2017 ◽  
pp. 295-314
Author(s):  
Tim Y. Hou ◽  
David N. McMurray ◽  
Robert S. Chapkin

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Lynne Shinto ◽  
Gail Marracci ◽  
Lauren Bumgarner ◽  
Vijayshree Yadav

In multiple sclerosis (MS), compromised blood-brain barrier (BBB) integrity contributes to inflammatory T cell migration into the central nervous system. Matrix metalloproteinase-9 (MMP-9) is associated with BBB disruption and subsequent T cell migration into the CNS. The aim of this paper was to evaluate the effects of omega-3 fatty acids on MMP-9 levels and T cell migration. Peripheral blood mononuclear cells (PBMC) from healthy controls were pretreated with two types of omega-3 fatty acids, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). Cell supernatants were used to determine MMP-9 protein and activity levels. Jurkat cells were pretreated with EPA and DHA and were added to fibronectin-coated transwells to measure T cell migration. EPA and DHA significantly decreased MMP-9 protein levels, MMP-9 activity, and significantly inhibited human T cell migration. The data suggest that omega-3 fatty acids may benefit patients with multiple sclerosis by modulating immune cell production of MMP-9.


Sign in / Sign up

Export Citation Format

Share Document